R. Kerry Clark's most recent trade in Elevance Health Inc was a trade of 601 Common Stock done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevance Health | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 601 | 9,640 (0%) | 0% | 0 | Common Stock | |
| Textron | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 2,794 | 9,067 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 9,039 (0%) | 0% | 0 | Common Stock | |
| Textron | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 1,756 | 6,273 (0%) | 0% | 0 | Common Stock | |
| Textron | R. Kerry Clark | Director | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 27 Oct 2023 | 9,353 | 4,517 (0%) | 0% | 75.1 | 702,448 | Common Stock |
| General Mills | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2023 | 2,760 | 61,904 (0%) | 0% | 0 | Common Stock | |
| Textron | R. Kerry Clark | Director | Sale of securities on an exchange or to another person at price $ 75.33 per share. | 22 Aug 2023 | 5,000 | 13,870 (0%) | 0% | 75.3 | 376,645 | Common |
| Elevance Health | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 8,651 (0%) | 0% | 0 | Common Stock | |
| Textron | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 2,517 | 18,870 (0%) | 0% | 0 | Common | |
| General Mills | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2022 | 2,309 | 59,144 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 8,194 (0%) | 0% | 0 | Common Stock | |
| Textron | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 2,174 | 16,353 (0%) | 0% | 0 | Common | |
| General Mills | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 3,034 | 56,835 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 7,754 (0%) | 0% | 0 | Common Stock | |
| Textron | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 2,349 | 14,179 (0%) | 0% | 0 | Common | |
| General Mills | R. Kerry Clark | Director | Sale of securities on an exchange or to another person at price $ 61.41 per share. | 05 Apr 2021 | 11,398 | 53,801 (0%) | 0% | 61.4 | 699,927 | Common Stock |
| General Mills | R. Kerry Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 11,398 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| General Mills | R. Kerry Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.48 per share. | 05 Apr 2021 | 11,398 | 65,199 (0%) | 0% | 39.5 | 449,993 | Common Stock |
| General Mills | R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2020 | 3,104 | 53,801 (0%) | 0% | 0 | Common Stock |